Drug Development and Therapeutics, a publication of Organization of Pharmaceutical Unity with BioAllied Sciences (OPUBS), is a peer-reviewed online journal with Semiannual print on demand compilation of issues published. The journal’s full text is available online at http://www.ddtjournal.org. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository. The journal does not charge for submission, processing or publication of manuscripts and even for color reproduction of photographs.
Abstracting and Indexing Information
The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Exlibris – Primo Central, Gale, Google Scholar, Hinari, Infotrieve, Journal Guide, National Science Library, OpenJGate, ProQuest, TdNet
The journal is indexed with, or included in, the following:
Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp
Open Access Publication and Creative Commons Licensing
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.
Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.
CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal technical effort and using cheaply available hardware.
Ahead of Print policy
Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.
The Drug Development and Therapeutics journal publishes original research work, review articles and commentary on contemporary pharmaceutical and clinical research issues. The scope of the journal covers various aspects of drug development and therapeutics including natural products, target validation, targeted drug discovery, High-throughput screening, Combinatorial chemistry, and library design, Drug delivery, ADME/Tox, PK/PD, pharmacology, Pharmaceutical formulation, Genomics and proteomics, molecular modeling, Bioinformatics, vaccines, clinical trial evaluations. Along with quantitative research work, this journal also invites case studies encompassing the area of drug development and therapeutics from industry, clinicians and academia.The journal will cover technical and clinical studies related to health, ethical and social issues in field of Pharmaceutical sciences, medicinal/analytical sciences, Biotechnology, Bioallied sciences. Articles with clinical interest, drug synthesis and development and implications will be given preference.